Modulation of Quinol/Quinone-Thioether Toxicity by Intramolecular Detoxication

References

• Sies H., Ketterer B. Glutathione Conjugation. Mechanisms and Biological Significance. Academic Press, San Diego 1988
   Google Scholar
• Anders M. W., Dekant W. Advances in Pharmacology. Conjugation-Dependent Carcinogenicity and Toxicology of Foreign Compounds. Academic Press, New York 1994; Vol. 27
   Google Scholar
• Monks T. J., Lau S. S. Toxicology of quinone-thioethers. CRC Crit. Rev. Toxicol. 1992; 22: 243–270
   Google Scholar
• Monks T. J., Lau S. S. Glutathione conjugation as a mechanism for the transport of reactive metabolites. Advances in Pharmacology, Vol. 27: Conjugation-Dependent Carcinogenicity and Toxicology of Foreign Compounds, M. W. Anders, W. Dekant. Academic Press, New York 1994; 183–210
   Google Scholar
• Eyer P., Kiese M. Biotransformation of 4-dimethylaminophenol: Reaction with glutathione, and some properties of the reaction products. Chem.-Biol. Interact. 1976; 14: 165–178
   PubMed Web of Science ®Google Scholar
• Wefers H., Sies H. Hepatic low-level chemiluminesence during redox cycling of menadione and the menadione-glutathione conjugate: Relation to glutathione and NAD(P)H: quinone reductase (DT-diaphorase) activity. Arch. Biochem. Biophys. 1983; 224: 568–578
   PubMed Web of Science ®Google Scholar
• Ross D., Larsson R., Norbeck K., Ryhage R., Moldeus P. Characterization and mechanism of formation of reactive products formed during peroxidase-catalysed oxidation of /j-phenetidine. Mol. Pharmacol 1985; 27: 277–288
   PubMed Web of Science ®Google Scholar
• Potter D. W., Miller D. W., Hinson J. A. Horseradish peroxidase-catalysed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione. Mol. Pharmacol. 1986; 29: 155–162
   PubMed Web of Science ®Google Scholar
• Wolff S. P., Spector A. Pro-oxidant activation of ocular reduc-tants. 2. Lens epithelial cell cytotoxicity of a dietary quinone is associated with a stable free radical formed with glutathione. in vitro, Exp. Eye Res 1987; 45: 791–801
   PubMed Web of Science ®Google Scholar
• Takahashi N., Schreiber J., Fischer V., Mason R. P. Formation of glutathione-conjugated semiquinones by the reaction of quino-nes with glutathione: An ESR study. Arch. Biochem. Biophys. 1987; 252: 41–48
   PubMed Web of Science ®Google Scholar
• Rao D. N. R., Takahashi N., Mason R. P. Characterization of a glutathione conjugate of the 1,4-benzosemiquinone-free radical formed in rat hepatocytes. J. Biol. Chem. 1988; 263: 17981–17986
   PubMed Web of Science ®Google Scholar
• Brown P. C., Dulik D. M., Jones T. W. The toxicity of menadione (2-methyl-l,4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells. Arch. Biochem. Biophys. 1991; 285: 187–196
   PubMed Web of Science ®Google Scholar
• Chung H., Harvey R. G., Armstrong R. N., Jarabak J. Poly-cyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase. J. Biol. Chem. 1987; 262: 12448–12451
   PubMed Web of Science ®Google Scholar
• van Ommen B., Besten C. Den, Rutten A. C. M., Ploemen J. H. T. M., Voo R. M. E., Muller M., van Bladeren P. J. Active site-directed irreversible inhibition of glutathione 5-trans-ferases by the glutathione conjugate of tetrachloro-l,4-benzoquinone. J. Biol. Chem. 1988; 263: 12939–12942
   PubMed Web of Science ®Google Scholar
• van Ommen B., Ploemen J. H. T. M., Ruven H. J., Vos R. M. E., Boggards J. J. P., van Berkel W. J. H., van Bladeren P. J. Studies on the active site of rat glutathione S-transferase isoenzyme 4–4. Chemical modification by tetrachloro-l,4-benzoquinone and its glutathione conjugate. Eur. J. Biochem. 1989; 181: 423–429
   PubMedGoogle Scholar
• Vos R. M. E., van Ommen B., Hoekstein M. S. J., de Goede J. H. M., van Bladeren P. J. Irreversible inhibition of rat hepatic glutathione 5-transferase isoenzymes by a series of structurally related quinones. Chem.-Biol. Interact. 1989; 71: 381–392
   PubMed Web of Science ®Google Scholar
• Buffinton G. D., Ollinger K., Brunmark A., Cadenas E. DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and glutathionyl-quinone conjugates. Biochem. J. 1989; 257: 561–571
   PubMed Web of Science ®Google Scholar
• van Ommen B., Ploemen J. P., Bogaards J. J. P., Monks T. J., Lau S. S., van Bladeren P. J. Irreversible inhibition of rat glutathione 5-transferase 1–1 by quinones and their glutathione conjugates: Structure-activity relationship and mechanism. Biochem. J. 1991; 276: 661–666
   PubMed Web of Science ®Google Scholar
• Jarabak J. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductase. Arch. Biochem. Biophys. 1991; 291: 334–338
   PubMed Web of Science ®Google Scholar
• Jarabak J., Harvey R. G. Studies on three reductases which have polycyclic aromatic hydrocarbons as substrates. Arch. Biochem. Biophys. 1993; 303: 394–401
   PubMed Web of Science ®Google Scholar
• Monks T. J., Lau S. S., Highet R. J., Gillette J. R. Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. Drug Metab. Dispos. 1985; 13: 553–559
   PubMed Web of Science ®Google Scholar
• Monks T. J., Highet R. J., Lau S. S. 2-Bromo-(diglutathion-5-yl)hydroquinone nephrotoxicity. Physiological, biochemical and electrochemical determinants. Mol. Pharmacol. 1988; 34: 492–500
   PubMed Web of Science ®Google Scholar
• Lau S. S., Hill B. A., Highet R. J., Monks T. J. Sequential oxidation and glutathione addition to 1,4-benzoquinone: Correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 1988; 34: 829–836
   PubMed Web of Science ®Google Scholar
• Redegeld F. A. M., Hofman G. A., van der Loo P. G. F., Koster A. S., Noordhoek J. Nephrotoxicity of the GSH conjugate of menadione (2-methyl-1,4-naphthoquinone) in the isolated perfused rat kidney. Role of metabolism by γ-glutamyl transpeptidase and probenecid-sensitive transport. J. Pharmacol. Exp. Ther. 1989; 256: 665–669
   Web of Science ®Google Scholar
• Lau S. S., Jones T. W., Highet R. J., Hill B. A., Monks T. J. Differences in the localization and extent of the renal proximal tubular necrosis caused by mercapturic acid and glutathione conjugates of menadione and 1,4-naphthoquinone. Toxicol. Appl. Pharmacol. 1990; 104: 334–350
   PubMed Web of Science ®Google Scholar
• Fowler L. M., Moore R. D., Foster J. R., Lock E. A. Nephrotoxicity of 4-aminophenol glutathione conjugate. Human Exp. Toxicol. 1991; 10: 451–459
   PubMed Web of Science ®Google Scholar
• Mertens J. J. W. M., Temmink J. H. M., van Bladeren P. J., Jones T. W., Lo H. H.-, Lau S. S., Monks T. J. Inhibition of γ-glutamyl transpeptidase potentiates the nephrotoxicity of glutathione conjugated chlorohydroquinones. Toxicol. Appl. Pharmacol. 1991; 110: 45–60
   PubMed Web of Science ®Google Scholar
• Monks T. J., Jones T. W., Hill B. A., Lau S. S. Nephrotoxicity of 2-bromo-(cystein-5-yl)hydroquinone and 2-bromo-(N-acetylcystein-S-yl)hydroquinone thioethers. Toxicol. Appl. Pharmacol. 1991; 111: 279–298
   PubMed Web of Science ®Google Scholar
• Klos C., Koob M., Kramer C., Dekant W. p-Aminophenol nephrotoxicity: Biosynthesis of toxic glutathione conjugates. Toxicol. Appl. Pharmacol. 1992; 115: 98–106
   PubMed Web of Science ®Google Scholar
• Larsson R., Boutin J., Moldeus P. Peroxidase-catalysed metabolic activation of xenobiotics. Metabolism of Xenobiotics, J. W. Gorrod, H. Oelschlager, J. Caldwell. Taylor and Francis, New York 1988; 43–50
   Google Scholar
• Canales P. L., Kleiner H. E., Monks T. J., Lau S. S. Formation of 8-hydroxy-deoxygaunonsine by quinol-thioethers. Toxicologist 1993; 13: 202, abstract
   Google Scholar
• Andrews J. E., Rogers J. M., Ebron-McCoy M., Logsdon T. R., Monks T. J., Lau S. S. Developmental toxicity of 2-bromo-hydroquinone (BHQ) and BHQ-glutathione conjugates in vivo and in whole embryo culture. Toxicol. Appl. Pharm. 1993; 120: 1–7
   PubMed Web of Science ®Google Scholar
• Curthoys N. P. Extracellular Catabolism of Glutathione. Research Monographs in Cell and Tissue Physiology, Vol. 14: Mammalian Ectoenzymes, A. J. Kenny, A. J. Turner. Elsevier Science Publishers, Amsterdam 1987; 249–264
   Google Scholar
• Lau S. S., Monks T. J. The in vivo disposition of 2-bromo-[14C]-hydroquinone and the effect of γ-glutamyl transpeptidase inhibition. Toxicol. Appl. Pharmacol. 1990; 103: 121–132
   PubMed Web of Science ®Google Scholar
• Monks T. J., Lo H. H.-, Lau S. S. Oxidation and acetylation as determinants of 2-bromo-(cystein-5-yl)hydroquinone mediated nephrotoxicity. Chem. Res. Toxicol. 1994; 7: 495–502
   PubMed Web of Science ®Google Scholar
• Hill B. A., Monks T. J., Lau S. S. Metabolism of 2-(gluta-thion-5-yl)hydroquinone and 2,3,5-(triglutathion-5-yl)hydroquinone in the in situ perfused rat kidney: Relationship to nephrotoxicity. Toxicol. Appl. Pharmacol. 1994; 129: 121–132
   PubMed Web of Science ®Google Scholar
• Allen L., Meek R. A., Yunis A. The inhibition of γ-glutamyl transpeptidase from human pancreatic carcinoma cells by (αS,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125;NSC-163501). Res. Commun. Chem. Pathol. Pharmacol. 1980; 27: 175–182
   PubMedGoogle Scholar
• Stole E., Seddon A. P., Wellner D., Meister A. Identification of a highly reactive threonine residue at the active site of γ-glutamyl transpeptidase. Proc. Natl. Acad. Sci. USA 1990; 87: 1706–1709
   PubMed Web of Science ®Google Scholar
• Tate S. S., Meister A. Serine-borate complex as a transition-state inhibitor of γ-glutamyl transpeptidase. Proc. Natl. Acad. Sci. USA 1978; 45: 4806–4809
   Google Scholar
• Elce J. S. Active-site amino acid residues in γ-glutamyltransferase and the nature of the γ-glutamyl-enzyme bond. Biochem. J. 1980; 185: 473–481
   PubMed Web of Science ®Google Scholar
• Allison R. D. γ-Glutamyl transpeptidase: Kinetics and mechanism. Meth. Enzymol. 1985; 113: 419–437
   PubMed Web of Science ®Google Scholar
• Szewczuk A., Connell G. E. The reaction of iodoacetamide with the active center of γ-glutamyl transpeptidase. Biochim. Biophys. Acta 1965; 105: 352–367
   PubMed Web of Science ®Google Scholar
• Schasteen C. S., Curthoys N. P., Reed D. J. The binding mechanism of glutathione and the anti-tumor drug (aS,5S)-a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501) to γ-glutamyltransferase. Biochem. Biophys. Res. Commun. 1983; 112: 564–570
   PubMed Web of Science ®Google Scholar
• Fushiki T., Iwami K., Yasumoto K., Iwai K. Evidence for an essential arginyl residue in bovine milk γ-glutamyltransferase. J. Biochem. (Tokyo) 1983; 93: 795–800
   PubMed Web of Science ®Google Scholar
• Monks T. J., Highet R. J., Lau S. S. Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(gluta-thion-5-yl)hydroquinone. Mol. Pharmacol. 1990; 38: 121–127
   PubMed Web of Science ®Google Scholar
• Haenen H. E. M. G., Rogmans P., Temmink J. H. M., van Bladeren P. J. Differential toxicity of the two thioether conjugates of menadione in confluent monolayers of rat renal proximal tubular cells. Toxicol. In Vitro 1994; 8: 207–214
   PubMed Web of Science ®Google Scholar
• Lau S. S., Jones T. W., Sioco R., Hill B. A., Pinon R. K., Monks T. J. Species differences in renal γ-glutamyl transpeptidase activity do not correlate with susceptibility to 2-bromo-(diglutathion-5-yl)hydroquinone mediated nephrotoxicity. Toxicology 1990; 64: 291–311
   PubMed Web of Science ®Google Scholar
• Kleiner H. E., Monks T. J., Lau S. S. JV-Acetylation/N-deacetylation as a determinant of 2,3,5-(triglutathion-S-yl)hydroquinone mediated nephrotoxicity. Toxicologist 1993; 13: 241, abstract
   Google Scholar
• Duffel M. W., Jakoby W. B. Cysteine 5-conjugate N-acetyl-transferase from rat kidney microsomes. Mol. Pharmacol. 1982; 21: 444–448
   PubMed Web of Science ®Google Scholar